Go Pro

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:APDN

Applied DNA Sciences (APDN) Stock Price, News & Analysis

Applied DNA Sciences logo

About Applied DNA Sciences Stock (NASDAQ:APDN)

Key Stats

Today's Range
$4.61
$5.87
50-Day Range
$2.32
$6.15
52-Week Range
$0.29
$7.15
Volume
2.76 million shs
Average Volume
516,804 shs
Market Capitalization
$7.94 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Sell

Company Overview

Applied DNA Sciences Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
1st Percentile Overall Score

APDN MarketRank™: 

Applied DNA Sciences scored higher than 1% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Applied DNA Sciences has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    Applied DNA Sciences has received no research coverage in the past 90 days.

  • Read more about Applied DNA Sciences' stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Applied DNA Sciences is -0.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Applied DNA Sciences is -0.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Applied DNA Sciences has a P/B Ratio of 0.03. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Short Interest

    There is no current short interest data available for APDN.
  • Dividend Yield

    Applied DNA Sciences does not currently pay a dividend.

  • Dividend Growth

    Applied DNA Sciences does not have a long track record of dividend growth.

  • Search Interest

    1 people have searched for APDN on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Applied DNA Sciences insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    0.17% of the stock of Applied DNA Sciences is held by insiders.

  • Percentage Held by Institutions

    22.22% of the stock of Applied DNA Sciences is held by institutions.

  • Read more about Applied DNA Sciences' insider trading history.
Receive APDN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Applied DNA Sciences and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

APDN Stock News Headlines

Trump's New Dollar
Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result.tc pixel
Applied DNA Sciences Announces New CEO Appointment
Earnings Scheduled For August 26, 2025
Applied DNA Sciences Focuses on LineaRx for Growth
See More Headlines

APDN Stock Analysis - Frequently Asked Questions

Applied DNA Sciences Inc (NASDAQ:APDN) issued its earnings results on Thursday, August, 14th. The technology company reported ($34.00) EPS for the quarter, beating analysts' consensus estimates of ($37.50) by $3.50. The technology company earned $0.30 million during the quarter, compared to analyst estimates of $1.28 million. Applied DNA Sciences had a negative trailing twelve-month return on equity of 136.17% and a negative net margin of 399.91%.

Applied DNA Sciences's stock reverse split before market open on Sunday, June 1st 2025.The 1-15 reverse split was announced on Sunday, June 1st 2025. The number of shares owned by shareholders was adjusted after the market closes on Sunday, June 1st 2025. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Applied DNA Sciences investors own include Zomedica (ZOM), Jumia Technologies (JMIA), Nano Dimension (NNDM), NIO (NIO), Virgin Galactic (SPCE), AST SpaceMobile (ASTS) and Advanced Micro Devices (AMD).

Company Calendar

Last Earnings
8/14/2025
Today
7/06/2026
Fiscal Year End
9/30/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
PROTECTION - SFTY
Sub-Industry
Business Services
Current Symbol
NASDAQ:APDN
CIK
744452
Employees
70
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($923.81)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$6.99 million
Net Margins
-399.91%
Pretax Margin
-394.30%
Return on Equity
-136.17%
Return on Assets
-101.95%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.76
Quick Ratio
2.60

Sales & Book Value

Annual Sales
$3.74 million
Price / Sales
2.12
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$215.25 per share
Price / Book
0.03

Miscellaneous

Outstanding Shares
1,291,000
Free Float
1,289,000
Market Cap
$7.94 million
Optionable
Optionable
Beta
0.15

Social Links

10 Stocks Set to Soar in 2026 Cover

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:APDN) was last updated on 7/6/2026 by MarketBeat.com Staff.
From Our Partners